Technical Analysis for ITOS - iTeos Therapeutics, Inc.

Grade Last Price % Change Price Change
F 25.44 4.82% 1.17
ITOS closed down 10.14 percent on Monday, April 12, 2021, on 1.22 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Down
Historical ITOS trend table...

Date Alert Name Type % Chg
Lower Bollinger Band Walk Weakness 4.82%
Wide Bands Range Expansion 4.82%
Below Lower BB Weakness 4.82%
Down 3 Days in a Row Weakness 4.82%
Down 4 Days in a Row Weakness 4.82%
Down 5 Days in a Row Weakness 4.82%
Lower Bollinger Band Touch Weakness 4.82%
Oversold Stochastic Weakness 4.82%
Wide Bands Range Expansion -5.81%
Below Lower BB Weakness -5.81%
Older End-of-Day Signals for ITOS ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakdown about 2 hours ago
Down 2 % about 2 hours ago
Down 1% about 2 hours ago
Fell Below Previous Day's Low about 2 hours ago
Up 5% about 4 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for cancer patients. Its product pipeline includes EOS-850, a small molecule antagonist of the adenosine A2a receptor; and EOS-448, an antagonist of TIGIT or T-cell immunoreceptor with Ig and ITIM domains. The company was founded in 2011 and is based in Cambridge, Massachusetts with an additional location in Gosselies, Belgium.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Adenosine Therapeutics For Cancer

Is ITOS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 47.61
52 Week Low 17.5
Average Volume 249,732
200-Day Moving Average 0.00
50-Day Moving Average 36.51
20-Day Moving Average 33.47
10-Day Moving Average 31.71
Average True Range 3.20
ADX 15.29
+DI 18.55
-DI 35.77
Chandelier Exit (Long, 3 ATRs ) 34.39
Chandelier Exit (Short, 3 ATRs ) 33.62
Upper Bollinger Band 40.75
Lower Bollinger Band 26.19
Percent B (%b) -0.13
BandWidth 43.49
MACD Line -2.35
MACD Signal Line -1.43
MACD Histogram -0.9171
Fundamentals Value
Market Cap 850.54 Million
Num Shares 35 Million
EPS -0.88
Price-to-Earnings (P/E) Ratio -27.52
Price-to-Sales 0.00
Price-to-Book 2.98
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 28.59
Resistance 3 (R3) 28.98 27.94 27.87
Resistance 2 (R2) 27.94 26.84 27.74 27.63
Resistance 1 (R1) 26.10 26.16 25.58 25.71 27.39
Pivot Point 25.06 25.06 24.80 24.86 25.06
Support 1 (S1) 23.22 23.96 22.70 22.83 21.15
Support 2 (S2) 22.18 23.28 21.98 20.91
Support 3 (S3) 20.34 22.18 20.67
Support 4 (S4) 19.95